Co-administration of ZYFLO CR with theophylline, warfarin and/or propranolol warrants close monitoring and dosage adjustments of the co-administered drug. Upon initiation of ZYFLO CR in patients receiving theophylline, the theophylline dosage should be reduced by approximately one-half and plasma theophylline concentrations monitored.

Understanding Asthma | About ZYFLO CR | Full Prescribing Information | For Patients | For Healthcare Professionals | ZYFLO Home | Contact Us | Terms of Use and Disclaimer | Privacy Policy

©2008 Critical Therapeutics, Inc.
Critical Therapeutics® is a registered trademark of Critical Therapeutics, Inc.
ZYFLO® is a registered trademark of Critical Therapeutics, Inc.
ZYFLO CR™ is a trademark of Critical Therapeutics, Inc.
DEY® is a registered trademark of Dey, L.P.
ZYF-Q307-40-01 July 2008.
This site is intended for residents of the U.S., Puerto Rico and U.S. territories.